CompoAtlas

InflaAide

InflaAide, licence 80094530: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Joyau santé Inc
NPN or DIN-HM
80094530
Status
Active licence
Licence date
20 September 2019
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Bromélaïne de fruit

Source : Bromélaïne de fruit

125.0 mgNot calculated
Bromélaïne de fruit

Source : Bromélaïne de fruit

9000000.0 Unités de papaïne du FCCNot calculated
Bromélaïne de fruit

Source : Ananas comosus var bracteatus - fruit

125.0 mgNot calculated
Bromélaïne de fruit

Source : Ananas comosus var bracteatus - fruit

9000000.0 Unités de papaïne du FCCNot calculated
Boswellia serrata

Source : Boswellia serrata - Oléorésine (écorce de tronc)

75.0 mgNot calculated
Serratiopeptidase

Source : Serratia - Cellule entière

60000.0 SUNot calculated
Curcuma longa

Source : Oléorésine

Extract : Matériel brut sec

Extraction ratio : 4.0:1.0

Dry plant equivalent : 600.0 mg

150.0 mgNot calculated
Curcuma longa

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 4.0:1.0

Dry plant equivalent : 600.0 mg

150.0 mgNot calculated
Acide 9-tétradécénoïque, ester d'hexadécyle, (Z)-

Source : Myristoléate de cétyle

100.0 mgNot calculated

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)1.0 Capsule2.0 Jour

Uses authorised in Canada

Le curcuma est utilisé traditionnellement en phytothérapie/herboristerie comme un anti-inflammatoire pour aider à soulager la douleur articulaire.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80094530

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line